BGLC
Bionexus Gene Lab
$1.37
−$0.14 (−9.27%)Jul 27, 2026
Key metrics
The numbers that frame BGLC today
- Market cap
- $3.31M
- P/E (TTM)
- -1.1
- EV / FCF
- -1.9
- Gross margin
- 14.5%
- EV / Sales
- 0.4
- ROIC
- -42.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.07
- 52wk High
- $8.98
Growth
Revenue and earnings trend for BGLC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BGLC
Is Bionexus Gene Lab a good buy?
No. Bionexus Gene Lab has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Bionexus Gene Lab is selling at a very high price.
What is the market capitalization of BGLC?
Bionexus Gene Lab's market capitalization is $3.31M.
What is the P/E ratio for BGLC stock?
Bionexus Gene Lab's current P/E ratio is -1.1.
What is the 52-week high for BGLC stock?
The 52-week high for Bionexus Gene Lab is $8.98. The current close of $1.37 is 84.7% below that high.
What is the 52-week low for BGLC stock?
The 52-week low for Bionexus Gene Lab is $1.07. The current close of $1.37 is 28% above that low.
Does BGLC stock pay dividends?
Bionexus Gene Lab does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BGLC?
Bionexus Gene Lab's Debt / Equity ratio is 0.04.